Table 1 Correlation between TET3 and clinicopathological features in 299 ESCC patients
Variables | NO. of patients | TET3 expression | P | |
|---|---|---|---|---|
Low | High | |||
Age | ||||
  < 60 | 156 | 72(46) | 84(54) | 0.627 |
  ≥ 60 | 143 | 62(43) | 81(57) | |
Gender | ||||
 Male | 231 | 95(41) | 136(59) | 0.018 |
 Female | 68 | 39(57) | 29(43) | |
Smoking status | ||||
 Smokers | 163 | 68(42) | 95(58) | 0.238 |
 Non-smokers | 136 | 66(49) | 70(51) | |
Differentiation | ||||
 I | 19 | 13(68) | 6(32) | 0.033 |
 II-III | 280 | 121(43) | 159(57) | |
Tumor invasion depth | ||||
 T1–2 | 117 | 58(50) | 59(50) | 0.185 |
 T3–4 | 182 | 76(42) | 106(58) | |
Tumor stage | ||||
 I-II | 189 | 85(45) | 104(55) | 0.943 |
 III-IV | 110 | 49(45) | 61(55) | |
Lymph node metastasis | ||||
 Yes | 178 | 86(48) | 92(52) | 0.140 |
 No | 121 | 48(40) | 73(60) | |
Tumor size | ||||
  < 3 cm | 110 | 57(52) | 53(48) | 0.063 |
  ≥ 3 cm | 189 | 77(41) | 112(59) | |